Pembrolizumab Concurrent With and Following Carbon-ion Radiotherapy for Locally Advanced Cervical Adenocarcinoma (BROTHER STUDY)
Latest Information Update: 07 Feb 2025
At a glance
- Drugs Pembrolizumab (Primary)
- Indications Adenocarcinoma; Cervical cancer; Squamous cell cancer; Uterine cancer
- Focus Therapeutic Use
- Acronyms BROTHER STUDY
Most Recent Events
- 07 Feb 2025 New trial record